FRIDAY, July 15, 2005 (HealthDay News) -- The U.S. Food and Drug Administration has approved Clarinex RediTabs, Schering-Plough's prescription antihistamine in a form that dissolves without water, the company said Friday.
The once-daily tablet, to be available nationwide in September, will come in both 2.5 mg. and 5 mg. doses. The drug's new formulation was approved for the treatment of indoor and outdoor allergies or hives in people ages six and older.
A new "tutti fruitti" flavor is available for children, the company said. Clarinex was first FDA approved in December 2001.
Visit Schering-Plough's Web site to learn more.
